Public release date: 29-Aug-2011 [ Print | E-mail Share ] [ Close Window ] Virus attacks childhood cancers
Harmless soil-dwelling bacteria successfully kill cancer Public release date: 4-Sep-2011 [ Print | E-mail Share ] [ Close Window ] Contact: Laura Udakisl.firstname.lastname@example.org 44-118-988-1843Society for General Microbiology
15 August 2011Last updated at 12:04 ET By James Gallagher Health reporter, BBC News Scientists have discovered how cancerous cells can "elbow" their way out of tumours, offering clues for new drugs to prevent cancers spreading. They say they have identified a protein called JAK which helps cancerous cells generate the force needed to move. Cancer discovery offers hope of tackling spread of disease
A microscopic image shows two T cells binding to beads, depicted in yellow,… (Dr. Clinical trial raises hope for cancer treatment - latimes.com
Exercise is a "wonder drug" for cancer survivors and may even prevent the disease coming back, according to a new report. Macmillan Cancer Support said physical activity should be "prescribed" by doctors after "hard evidence" showed it can significantly help recovery and prevent other long-term illnesses. Exercise a 'wonder drug' that can stop cancer coming back - Scotsman.com News
Biologist says cancers might actually be newly-evolved species inside your body Posted by Xeno on July 26, 2011 We think of cancer as a disease, a form of runaway cell growth within an organism.
Low dose naltrexone LDN: Harnessing the body’s own chemistry to treat human ovarian cancer Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that a low dose of the opioid antagonist naltrexone LDN has an extraordinarily potent antitumor effect on human ovarian cancer in tissue culture and xenografts established in nude mice. When LDN is combined with chemotherapy, there is an additive inhibitory action on tumorigenesis. This discovery, reported in the July 2011 issue of Experimental Biology and Medicine, provides new insights into the pathogenesis and treatment of ovarian neoplasia, the 4th leading cause of cancer-related mortality among women in the United States.The strategy of LDN therapy in repressing cancer was first reported over 30 years ago by Drs.
Formaldehyde Is Added to List of Carcinogens + (Aspartame Lupus claim) The government issued warnings on Friday about two materials used daily by millions of Americans, saying that one causes cancer and the other might.Government scientists listed formaldehyde as a carcinogen, and said it is found in worrisome quantities in plywood, particle board, mortuaries and hair salons. They also said that styrene, which is used in boats, bathtubs and in disposable foam plastic cups and plates, may cause cancer but is generally found in such low levels in consumer products that risks are low.Frequent and intense exposures in manufacturing plants are far more worrisome than the intermittent contact that most consumers have, but government scientists said that consumers should still avoid contact with formaldehyde and styrene along with six other chemicals that were added Friday to the government’s official Report on Carcinogens.
Cancer cells accelerate aging and inflammation in the body to drive tumor growth
Through the results of widespread experimentation of the… well… let’s say “non-scientific” variety, it’s pretty well known that marijuana has the side effect of making the user very hungry.
Public release date: 6-Apr-2011 [ Print | E-mail Share ] [ Close Window ] Contact: Nicole Fawcettnfawcett@umich.edu 734-764-2220University of Michigan Health System New drug shrinks cancer in animals, U-M study shows
'Good cholesterol' nanoparticles seek and destroy cancer cells Public release date: 1-Apr-2011 [ Print | E-mail Share ] [ Close Window ]
Cancer turns out to be a p53 protein aggregation disease Protein aggregation, generally associated with Alzheimer’s and mad cow disease, turns out to play a significant role in cancer. In a paper published in Nature Chemical Biology, Frederic Rousseau and Joost Schymkowitz of VIB, K.U.Leuven and Vrije Universiteit Brussel describe that certain mutations of p53, an important tumor suppressor, cause the protein to misfold in a way that the proteins start to aggregate. This not only disrupts the protective function of normal p53, but of other related proteins as well.
Single-cell blood test offers hope for future cancer patients